1. Home
  2. XELB vs CURX Comparison

XELB vs CURX Comparison

Compare XELB & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$1.55

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

CURX

Curanex Pharmaceuticals Inc

N/A

Current Price

$0.48

Market Cap

11.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XELB
CURX
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
11.6M
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
XELB
CURX
Price
$1.55
$0.48
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
42.2K
5.4M
Earning Date
11-19-2025
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$83.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.26
52 Week High
$4.20
$9.18

Technical Indicators

Market Signals
Indicator
XELB
CURX
Relative Strength Index (RSI) 49.26 61.12
Support Level $1.51 $0.37
Resistance Level $1.60 $0.51
Average True Range (ATR) 0.19 0.05
MACD 0.02 0.01
Stochastic Oscillator 63.04 63.18

Price Performance

Historical Comparison
XELB
CURX

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.

Share on Social Networks: